"Ozempic breasts" is an informal term used to describe changes in breast size, shape, and firmness that occur as a result of rapid weight loss associated with the use of Ozempic (semaglutide) and similar GLP-1 weight loss medications. These changes are not a direct side effect of the drug itself, but rather stem from the significant fat loss it induces, including fat in the breasts. Key features of these changes often include:
- Loss of breast volume, especially in the upper part of the breasts
- Sagging and drooping nipples
- Loose or crepey skin on the chest
- A deflated, less full appearance
- Increased sensitivity or soreness in some cases
These effects are similar to those seen with rapid weight loss from other causes and are linked to the reduction of fat tissue, which produces estrogen. Lower estrogen from fat loss can also affect breast tissue and sensation. Many women experiencing "Ozempic breasts" find these changes frustrating and sometimes seek cosmetic surgery such as breast lifts or implants to restore breast shape and volume. In summary, "Ozempic breasts" refers to breast changes caused by the rapid fat loss due to weight loss medications like Ozempic, rather than a direct drug side effect.
